Biocon Biologics Launches Biosimilar for Autoimmune Diseases in US
Biocon Biologics launches YESINTEK (ustekinumab-kfce), a biosimilar for Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis, in the US market.
Photograph: Kind courtesy Biocon Biologics/Facebook
New Delhi, Feb 24 (PTI) Biocon Biologics on Monday said it has launched a biosimilar product to treat certain autoimmune diseases, in the US market.
YESINTEK (ustekinumab-kfce), which is approved for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis, is now available to patients in the US, the company said in a statement.
The company's product is biosimilar to Stelara.
"The launch of YESINTEK marks a significant step in our commitment to improving the lives of patients with inflammatory conditions and expanding access to high-quality biosimilars," Biocon Biologics CEO & MD Shreehas Tambe said.
Biocon Biologics Inc Head of North America Josh Salsi said:"For healthcare providers, switching to YESINTEK offers a seamless treatment experience covering the same indications and dosing options.
YESINTEK (ustekinumab-kfce), which is approved for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis, is now available to patients in the US, the company said in a statement.
The company's product is biosimilar to Stelara.
"The launch of YESINTEK marks a significant step in our commitment to improving the lives of patients with inflammatory conditions and expanding access to high-quality biosimilars," Biocon Biologics CEO & MD Shreehas Tambe said.
Biocon Biologics Inc Head of North America Josh Salsi said:"For healthcare providers, switching to YESINTEK offers a seamless treatment experience covering the same indications and dosing options.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 8.10 (+ 18.94)
- 352104789
- GTL Infrastructure
- 1.50 (+ 7.14)
- 20981605
- G G Engineering
- 0.90 (+ 11.11)
- 20091512
- AvanceTechnologies
- 0.54 ( -8.47)
- 18780688
- YES Bank Ltd.
- 17.33 (+ 2.61)
- 14468022
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback